Association between TORCH infection and lupus anticoagulant antibody in pregnant women with recurrent abortion

被引:1
作者
Fatah, Hiwa R. [1 ]
机构
[1] Koya Univ, Fac Sci & Hlth, Dept Biol, Koya KOY45, Kurdistan Regio, Iraq
关键词
Toxoplasma; rubella; CMV; lupus anticoagulant antibody; pregnant women; CYTOMEGALOVIRUS; RISK;
D O I
10.14715/cmb/2023.69.13.25
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Abortion is a medical condition that describes pregnancy loss due to various causes including TORCH infections (toxoplasmosis, others (syphilis and hepatitis B), rubella, cytomegalovirus (CMV), and herpes simplex virus (HSV) infection). TORCH infections may pass to the fetus that has low immunity to fight the disease, besides; the complications are much higher during the early stages of pregnancy which may involve abortion. Therefore, investigating the possible factors that could be associated with TORCH infection including the clotting factor lupus anticoagulant antibody is vital. In this study, TORCH antibodies in 33 pregnant women were assessed and then lupus anticoagulant antibodies were tested using Diagnostica Stago STart 4 Hemostasis Analyzer. The serum concentration of immunoglobulin M (IgM) and immunoglobulin G (IgG) for toxoplasma, rubella and CMV were quantitatively determined with Cobas e411. The serum concentration of IgG for rubella and CMV increased in the blood were 90.9% and 66.6% of pregnant women respectively, while toxoplasma results showed an increasing level of IgG in 24.4% of patients. IgM levels for toxoplasma, rubella and CMV are elevated in 6.1%, 3.03% and 24.2% of patients respectively. Lupus anticoagulant antibody is increased in the blood of 72.7% of pregnant women. It was concluded that only rubella and CMV infections cause the increase of lupus anticoagulant antibodies in the tested pregnant women, not toxoplasmosis. Copyright: (c) 2023 by the C.M.B. Association. All rights reserved.
引用
收藏
页码:162 / 166
页数:5
相关论文
共 34 条
[1]  
Abu-Heija Adel, 2014, Sultan Qaboos Univ Med J, V14, pe26
[2]  
Akunaeziri UA., 2021, Trop J Obstet Gynaecol, V38, P128
[3]  
Amjadi N, 2023, Cell Mol Biomed Rep, V3, P222, DOI [10.55705/cmbr.2023.388391.1112, DOI 10.55705/CMBR.2023.388391.1112]
[4]  
ARIAS FERNANDO., 2008, Practical guide to high risk pregnancy and delivery, V3rd
[5]  
Baghel S, 2020, J S Asian Fed Obstet Gynaecol., V12, P377
[6]  
Bostanabad S. Zaker, 2017, Sarem Journal of Medical Research, V2, P43
[7]  
Cheshik S. G., 2016, Voprosy Virusologii, V61, P74, DOI 10.18821/0507-4088-2016-61-2-74-78
[8]  
Daftary SN, 2016, Holland & Brews manual of obstetrics
[9]   Congenital Cytomegalovirus Infection [J].
Dietrich, Monika L. ;
Schieffelin, John S. .
OCHSNER JOURNAL, 2019, 19 (02) :123-130
[10]  
El-Mekki AA, 1998, SAUDI MED J, V19, P575